Service Corporation International (SCI) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 Jan, 2026Strategic priorities and business model
Focused on growing revenue, leveraging scale, and deploying capital to drive long-term value.
Maintains a strong business model with a sustainable growth platform and significant cash flow.
Industry leader in innovation, technology, and preneed sales, with a differentiated backlog model.
Poised for incremental growth due to demographic tailwinds and market share gains.
Financial position and shareholder returns
Liquidity of $1.56B and leverage ratio of 3.65x, targeting a range of 3.5x–4.0x.
Returned ~$7.1B to shareholders via dividends and share repurchases since 2004, reducing outstanding shares by 57%.
Dividends per share have grown at a 16% CAGR from 2005–2024.
Delivered superior total shareholder returns over 3, 5, and 10 years compared to major indices.
Market position and scale
Largest player in the fragmented deathcare industry with $4.2B in revenue and ~17% market share in the U.S. and Canada.
Operates 1,989 locations, including 1,331 funeral homes and 496 cemeteries, with 62% of cemeteries co-located with funeral homes.
Employs 25,000 people and serves approximately 700,000 customers annually.
Latest events from Service Corporation International
- Urban network, pre-need backlog, and tech-driven efficiency fuel growth and future outlook.SCI
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Adjusted EPS rose 8% in Q4 and 9% for the year, with 2026 guidance targeting further growth.SCI
Q4 202513 Feb 2026 - Earnings growth, robust M&A, and tech-driven efficiency position the business for strong future gains.SCI
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20253 Feb 2026 - Normalized growth, margin expansion, and evolving cremation trends shape the outlook.SCI
BofA Securities Leveraged Finance Conference 20253 Feb 2026 - Q2 revenue up, adjusted EPS down; strong cash flow and capital returns; guidance at lower end.SCI
Q2 20242 Feb 2026 - Q3 2024 delivered stable profits, strong cash flow, and record acquisitions for future growth.SCI
Q3 202417 Jan 2026 - Stabilized volumes, moderated cremation shifts, and strong pre-need sales drive 2026 growth.SCI
UBS Global Healthcare Conference 202513 Jan 2026 - Strong market position, robust cash flow, and strategic growth drive superior shareholder returns.SCI
Investor presentation13 Jan 2026 - Strong market position, robust returns, and growth driven by scale and preneed strategy.SCI
Investor presentation13 Jan 2026